Merck's rare tumour drug Pimjetmi claims FDA approval

Coverage, in order

1. 15h ago
   first Pharmaphorum UK indie

   Merck's rare tumour drug Pimjetmi claims FDA approval

   Merck's rare tumour drug Pimjetmi claims FDA approval Phil.Taylor Wed, 11/11/2026 - 10:00

2. 2h ago
   
   MedCity News indie study

   Drug Approval Marks Another Win for Merck KGaA’s Rare Tumor Strategy

   Merck KGaA drug Pimjetmi is now FDA approved for treating tenosynovial giant cell tumor. This drug complements other rare tumor assets the Germany-based drugmaker has acquired in a series of business deals.

Alivewire groups outlets reporting the same story. Each headline links to the outlet that wrote it; nothing is republished here.